RxDoctor Payments Data

Phillip Ward, DPM

Podiatrist · Fayetteville, NCNPI 1396749198

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Modulated Imaging, Inc. accounts for 65.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $3,465 and has fallen 73.5% since, to $917 in 2025.

$6,678in general payments, 2019–2025

Across 55 payments — averaging $121.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modulated Imaging, Inc.$4K
  • Integra Lifesciences Corporation$538
  • Kerecis Limited$229
  • Aroa Biosurgery Incorporated$182
  • Smith+Nephew$180
  • Stryker$164
  • plus $997 from 18 others

What the payments were for

  • Consulting fees$3,42551%
  • Travel & lodging$90314%
  • Food & beverage$2,35135%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,678 in reported general payments places this provider in the 80th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$73,677
Medicare patients
383
Services billed
1,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl67$725
Ammonium Lactate24$648
Celecoxib26$617
Meloxicam140$542
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip32$388
Ciclopirox11$371
Terbinafine Hcl45$325
Methylprednisolone29$238
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim43$182
Ropinirole Hcl16$170
Gabapentin20$123
Triamcinolone Acetonide14$97

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fayetteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →